Abeona Therapeutics develops cell and gene therapies, led by ZEVASKYN, a treatment for skin wounds caused by a rare inherited skin disease. It last closed at $2.60 on Nov 17, up 0.00% on the day. The average 12-month price target from 3 analysts is $18.00 (+592.3% from the last close), with a high of $19.00 and a low of $17.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). In the past 30 days there were 1 dark pool print totaling $381K, the largest $381K.
Each firm's latest rating on ABEO in the past 90 days
Average 12-month target
$18.00
▲ 592.3% upside
Based on 3 analysts who set a price target on ABEO in the past 90 days. The average target is $18.00, with a high of $19.00 and a low of $17.00, compared with the last close of $2.60.
Low $17.00Avg $18.00High $19.00
Blue marker: last close $2.60
Highest target$19.00
Average target$18.00
Lowest target$17.00
Latest rating changes
HC Wainwright & Co.Maintained
Nov 12Buy$18
Cantor FitzgeraldTarget lowered
Nov 10Buy$30 → $19
Cantor FitzgeraldMaintained
Sep 18Buy$30
Roth CapitalInitiated
Sep 17Buy$17
OppenheimerMaintained
Aug 14Buy$21
Date
Firm
Action
Rating
Price target
Nov 12
HC Wainwright & Co.
Maintained
Buy
$18
Nov 10
Cantor Fitzgerald
Target lowered
Buy
$30 → $19
Sep 18
Cantor Fitzgerald
Maintained
Buy
$30
Sep 17
Roth Capital
Initiated
Buy
$17
Aug 14
Oppenheimer
Maintained
Buy
$21
Loading…
Technical Analysis
ABEO · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 42% below its 20 day and 76% below its 50 day average. It is 107% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the Pivot at $2.57, and the nearest resistance the Pivot R1 at $2.65.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 11.8%/day
Key levels
$7.6552 week high+194.2%
$5.50100 day average+111.5%
$5.37200 day average+106.5%
$4.67Swing high (Oct 21)+79.6%
$4.5750 day average+75.8%
$3.6820 day average+41.5%
$2.65Pivot R1+1.9%
$2.60Last close
$2.57Pivot−1.2%
$2.52Pivot S1−3.1%
$2.0952 week low−19.6%
Indicators
RSI (14)
26.45
Oversold below 30
Oversold
MACD
-0.65
Below its signal line
Bearish
Stochastic
17.1
Near the bottom of its range
Oversold
ADX (14)
43.8
Strong downtrend
Williams %R
-80.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-88.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−38.8%
Change over 10 sessions
Bearish
ATR (14)
$0.31
Typical daily range, 11.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 25.7%/day
Key levels
$7.6552 week high+194.2%
$5.50100 day average+111.5%
$5.37200 day average+106.5%
$4.67Swing high (Oct 21)+79.6%
$4.5750 day average+75.8%
$3.6820 day average+41.5%
$2.65Pivot R1+1.9%
$2.60Last close
$2.57Pivot−1.2%
$2.52Pivot S1−3.1%
$2.0952 week low−19.6%
Indicators
RSI (14)
26.44
Oversold below 30
Oversold
MACD
-0.64
Below its signal line
Bearish
Stochastic
8.3
Near the bottom of its range
Oversold
ADX (14)
26.6
Trending down
Williams %R
-87.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-189.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−52.0%
Change over 10 sessions
Bearish
ATR (14)
$0.67
Typical daily range, 25.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ABEO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ABEO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ABEO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ABEO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABEO is in one of them and how their past ABEO trades turned out.
Abeona Therapeutics is a biopharmaceutical company based in Cleveland, Ohio, that develops cell and gene therapies for rare genetic diseases. Its main product, ZEVASKYN, treats skin wounds in patients with recessive dystrophic epidermolysis bullosa, a rare inherited skin disease. The treatment uses a patient's own skin cells, which are modified and applied surgically at specialized treatment centers. Its pipeline also includes gene therapies for eye diseases.